References
- Antoni M, Lutgendorf S, Cole S, et al (2006). The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer, 6, 240-248. https://doi.org/10.1038/nrc1820
- Antonova L, Aronson K, Mueller C, (2011). Stress and breast cancer: from epidemiology to molecular biology. Breast Cancer Res, 13, 208. https://doi.org/10.1186/bcr2836
- Ben-Eliyahu S, Shakhar G, Page G, et al (2000). Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors. Neuroimmunomodulation, 8, 154-164 https://doi.org/10.1159/000054276
- Bradlow H, Sepkovic D, (2004). Steroids as procarcinogenic agents. Ann N Y Acad Sci, 1028, 216-32. https://doi.org/10.1196/annals.1322.027
- Carruba, G, 2006. Estrogens and mechanisms of prostate cancer progression. Ann N Y Acad Sci, 1089, 201-217. https://doi.org/10.1196/annals.1386.027
- Chida Y, Steptoe A, (2008). Positive psychological wellbeing and mortality: a quantitative review of prospective observational studies. Psychosom Med, 70, 741-756. https://doi.org/10.1097/PSY.0b013e31818105ba
- Dagogo-Jack S, (2001). Human leptin regulation and promise in pharmacotherapy. Curr Drug Targets, 2, 181-95. https://doi.org/10.2174/1389450013348623
- Dieudonne M, Sammari A, Dos Santos E, et al (2006). Sex steroids and leptin regulate 11-hydroxysteroid dehydrogenase 1 and p450 aromatase expressions in human preadipocytes: sex specificities. J Steroid Biochem Mol Biol, 99, 189-196. https://doi.org/10.1016/j.jsbmb.2006.01.007
- Dubois V, Jarde T, Delort L, et al (2014). Leptin induces a proliferative response in breast cancer cells but not in normal breast cells. Nutr Cancer, 66, 645-55 https://doi.org/10.1080/01635581.2014.894104
- Fabre B, Machulsky N, Grosman H, et al (2014). Life events are positively associated with luteinizing hormone in middle age adult men. Role of cortisol as a third variable. Stress, 17, 328-33. https://doi.org/10.3109/10253890.2014.930431
- Fleshner N, Zlotta A, (2007). Prostate cancer prevention: past, present, and future. Cancer, 110, 1889-99. https://doi.org/10.1002/cncr.23009
- Fradet V, Cheng I, Casey G, et al (2009). Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res, 15, 2559-66. https://doi.org/10.1158/1078-0432.CCR-08-2503
- Freedland S, Aronson W, (2009). Dietary intervention strategies to modulate prostate cancer risk and prognosis. Curr Opin Urol, 19, 263-7. https://doi.org/10.1097/MOU.0b013e328329ea6c
- Garssen B (2004). Psychological factors and cancer development: evidence after 30 years of research. Clin Psychol Rev, 24, 315-38. https://doi.org/10.1016/j.cpr.2004.01.002
- Gidron Y, Fabre B, Grosman H, et al (2011). Life events, cortisol and levels of prostate specific antigen: A story of synergism. Psychoneuroendocrinol, 36, 874-80. https://doi.org/10.1016/j.psyneuen.2010.11.011
- Gleason D (1992). Histologic grading of prostate cancer; a perspective. Hum Pathol, 23, 273-79. https://doi.org/10.1016/0046-8177(92)90108-F
- Hammarsten J, Damber J, Karlsson M, et al (2009). Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia. Prostate Cancer Prostatic Dis, 12, 160-5. https://doi.org/10.1038/pcan.2008.50
- Masuzaki H, Ogawa Y, Hosoda K, et al (1997). Glucocorticoid regulation of leptin synthesis and secretion in humans: Elevated plasma leptin levels in Cushing's syndrome. J Clin Endocrinol Metab, 82, 2542-7.
- McMurtry V, Simeone A, Nieves-Alicea R, et al (2009). Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells. Clin Exp Metastasis, 26, 197-204. https://doi.org/10.1007/s10585-008-9231-x
- Mravec B, Gidron Y, Hulin I, 2008. Neurobiology of cancer: Interactions between nervous, endocrine and immune systems as a base for monitoring and modulating the tumorigenesis by the brain. Semin Cancer Biol, 18, 150-163. https://doi.org/10.1016/j.semcancer.2007.12.002
- Pasquali R, Vicennati V, Cacciari M et al (2006). The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann N Y Acad Sci, 1083, 111-128. https://doi.org/10.1196/annals.1367.009
- Ray A, Nkhata K, Cleary M, (2007). Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status. Int J Oncol, 30, 1499-509.
- Risbridger G, Bianco J, Ellem S, et al (2003). Oestrogens and prostate cancer. Endocr Relat Cancer, 10, 187-191. https://doi.org/10.1677/erc.0.0100187
- Shaikh M, Grundy R, Kirk J, (2008). Hyperleptinaemia rather than fasting hyperinsulinaemia is associated with obesity following hypothalamic damage in children. Eur J of Endocrinol, 159, 791-7. https://doi.org/10.1530/EJE-08-0533
- Simpson E, (2000). Biology of aromatase in the mammary gland. J Mammary Gland Biol Neoplasia, 5, 251-258. https://doi.org/10.1023/A:1009590626450
- Slieker L, Sloop K, Surface P, et al (1996). Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem, 271, 5301-4. https://doi.org/10.1074/jbc.271.10.5301
- Turnbull A, Rivier C, (1999). Regulation of the hypothalamicpituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev, 79, 1-71. https://doi.org/10.1152/physrev.1999.79.1.1
- Chou Y, Chou W, Hsu G, et al (2009). Circulating levels of leptin, adiposity and breast cancer risk. Br J Cancer, 100, 578-582. https://doi.org/10.1038/sj.bjc.6604913
- Vermeulen A, Verdonck L, Kaufman J, (1999). A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab, 84, 3666-72. https://doi.org/10.1210/jcem.84.10.6079
- Wiklund F, Lageros Y, Chang E, et al (2008). Lifetime total physical activity and prostate cancer risk: a population-based case-control study in Sweden. Eur J Epidemiol, 23, 739-46 https://doi.org/10.1007/s10654-008-9294-7
-
Williams G, (2012). Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant
$ER-{\alpha}$ and GPER signaling. Mol Cell Endocrinol, 351, 269-78. https://doi.org/10.1016/j.mce.2011.12.017 - Williams G, (2010). The role of oestrogen in the pathogenesis of obesity, type 2 diabetes, breast cancer and prostate disease. Eur J Cancer Prev, 19, 256-71. https://doi.org/10.1097/CEJ.0b013e328338f7d2